Effects of ADAM 10 upregulation on progression, migration, and prognosis of nasopharyngeal carcinoma
Author:
Affiliation:
1. Department of Otorhinolaryngology Head and Neck Surgery Affiliated Hospital of Nantong University Nantong China
2. Department of Pathology Medical School of Nantong University Nantong China
Funder
China Postdoctoral Science Foundation
Natural Science Foundation of Jiangsu Province
Publisher
Wiley
Subject
Cancer Research,Oncology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12800
Reference36 articles.
1. N,N′-Dinitrosopiperazine-mediated Ezrin Protein Phosphorylation via Activation of Rho Kinase and Protein Kinase C Is Involved in Metastasis of Nasopharyngeal Carcinoma 6-10B Cells
2. Epidemiological trends of nasopharyngeal carcinoma in China;Wei KR;Asian Pac J Cancer Prev,2010
3. Global Cancer Statistics, 2002
4. Curcuminoids Suppress the Growth of Pharynx and Nasopharyngeal Carcinoma Cells through Induced Apoptosis
5. Overall Survival After Concurrent Cisplatin-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The deubiquitinase USP7 and E3 ligase TRIM21 regulate vasculogenic mimicry and malignant progression of RMS by balancing SNAI2 homeostasis;Journal of Experimental & Clinical Cancer Research;2024-05-04
2. ADAM22 acts as a novel predictive biomarker for unfavorable prognosis and facilitates metastasis via PI3K/AKT signaling pathway in nasopharyngeal carcinoma;Pathology - Research and Practice;2024-04
3. Differential expression of “A Disintegrin and Metalloproteinase 10” in hepatocellular carcinoma and the noncancerous hepatic tissues: Contribution to HCV-promoted hepatocarcinogenesis;Indian Journal of Pathology and Microbiology;2023
4. Efficacy of concurrent chemoradiotherapy combined with nimotuzumab in the treatment of nasopharyngeal carcinoma with cervical lymph node metastasis;European Archives of Oto-Rhino-Laryngology;2022-12-29
5. ADAM10 and ADAM17—Novel Players in Retinoblastoma Carcinogenesis;International Journal of Molecular Sciences;2022-10-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3